FIELD: medicine; pharmacology.
SUBSTANCE: composition is intended for treatment or prevention of insulin resistance of susceptible warm-blooded animals, including humans, and contains selective modulator of estrogen receptor EM-652-HC1, taken in amount determined by therapeutic efficiency.
EFFECT: effective treatment of prevention of insulin resistance development for warm-blooded mammals.
5 cl, 20 ex, 12 tbl, 8 dwg
Authors
Dates
2008-06-27—Published
2000-07-05—Filed